Chronic rhinosinusitis is inflammation of the sinuses and nasal passages that lasts at least 12 weeks. It causes ongoing symptoms, such as stuffy nose and facial pain or pressure. Although the ...

[99] Chronic rhinosinusitis with nasal polyps is characterized by eosinophilic inflammation and high IL-5 levels. The highest concentrations of IL-5 were found in NP tissue of subjects with ...

A new CT-scan based risk score facilitates the identification of patients at risk of revision endoscopic sinus surgery due to chronic rhinosinusitis. A new CT-scan based risk score facilitates the ...

Tezepelumab is an epithelial cytokine blocker used to treat severe asthma; its efficacy and safety in patients with chronic rhinosinusitis with nasal polyps have been unclear. New research ...

New Phase II data demonstrate amlitelimab’s efficacy in heterogeneous inflammatory asthma, as lunsekimig and itepekimab ...

These quiz questions about chronic rhinosinusitis with nasal polyps (CRSwNP) are derived from current literature. Are you up to date? At the end of the quiz, compare your score with those of your ...

A new CT-scan based risk score facilitates the identification of patients at risk of revision endoscopic sinus surgery due to chronic rhinosinusitis. This allows for early prediction of disease ...

Sanofi’s respiratory pipeline advances with new data in asthma and plans for new clinical studies in COPDNew phase 2 data for amlitelimab show ...

Itepekimab expanding into chronic rhinosinusitis along with COPD and bronchiectasis; phase 3 readouts in COPD in H2 2025 and bronchiectasis in 2026 Paris, April 15, 2025. Sanofi today shared new ...